Sanofi (SNYNF) Exchange Rate Effect (2013 - 2026)
Sanofi (SNYNF) posted Exchange Rate Effect of $10.5 million for Q1 2026, up 119.26% sequentially from -$54.7 million in Q4 2025, and up 150.08% YoY from $4.2 million in Q1 2025.
Sanofi (SNYNF) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Sanofi (SNYNF) has 9 years of Exchange Rate Effect data on file, last reported at $10.5 million in Q1 2026.
- Quarterly Exchange Rate Effect rose 150.08% year-over-year to $10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$132.2 million (down 169.94% YoY) and the FY2025 annual result came in at -$54.7 million, down 293.83% from the prior year.
- Exchange Rate Effect advanced to $10.5 million in Q1 2026 per SNYNF's latest filing, from -$54.7 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $10.5 million in Q1 2026, with the low at -$63.1 million in Q3 2025.
- Average Exchange Rate Effect over 3 years is -$22.6 million, with a median of -$17.5 million recorded in 2024.
- Year-over-year, Exchange Rate Effect slumped 293.83% in 2025 and jumped 150.08% in 2026.
- Sanofi's Exchange Rate Effect stood at -$13.9 million in 2024, then tumbled by 293.83% to -$54.7 million in 2025, then jumped by 119.26% to $10.5 million in 2026.
- Business Quant data shows SNYNF's Exchange Rate Effect at $10.5 million in Q1 2026, -$54.7 million in Q4 2025, and -$63.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 67.00 Mn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | -25.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -12.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -18.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -19.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | -11.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 19.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -77.00 Mn |
| 10 | Sanofi | - | - | 9.49 Bn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.54 Mn |
| Mar 31, 2026 | 10.54 Mn |
| Dec 31, 2025 | -54.71 Mn |
| Dec 31, 2025 | -54.71 Mn |
| Sep 30, 2025 | -63.13 Mn |
| Sep 30, 2025 | -63.13 Mn |
| Jun 30, 2025 | -24.90 Mn |
| Jun 30, 2025 | -24.90 Mn |
| Mar 31, 2025 | -21.04 Mn |
| Mar 31, 2025 | -21.04 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Jun 30, 2024 | -8.62 Mn |
| Jun 30, 2024 | -8.62 Mn |
| Mar 31, 2024 | -5.43 Mn |
| Mar 31, 2024 | -5.43 Mn |
| Dec 31, 2018 | -239.69 Mn |
| Dec 31, 2018 | -239.69 Mn |
| Dec 31, 2017 | 511.01 Mn |
| Dec 31, 2017 | 511.01 Mn |